About NuCryo Vascular Inc.
NuCryo Vascular Inc. is a Medical Device company, headquartered in San Jose, with 11 - 50 employees and annual revenue of $5M - $20M.
NuCryo Vascular LLC manufactures the PolarCath (Cryoplasty) Balloon Dilatation system. The Cryoplasty system is currently available in the United States The PolarCath Peripheral Dilatation System is indicated to dilate stenoses in the peripheral vasculature (iliac, femoral, popliteal, infrapopl...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
NuCryo Vascular Inc. Company Highlights
Corporate Office Address
2182;2184;2186;2188;2190;2192 Bering Drive
San Jose, 95131
Website
NuCryo Vascular Inc. Org
NuCryo Vascular Inc. has 1 Manager employees.
NuCryo Vascular Inc.'s Tech Stack
Frequently Asked Questions About
NuCryo Vascular Inc.
Log in or sign up to get full contact details and additional support.
How many senior employees does NuCryo Vascular Inc. have?
NuCryo Vascular Inc. has 1 senior employees that are typically used for decision making.
What technologies does NuCryo Vascular Inc. use?
NuCryo Vascular Inc. uses technologies including Cloudflare, GoDaddy, and Google Maps.
How do I contact NuCryo Vascular Inc.?
To contact NuCryo Vascular Inc., visit polarcath.com.
What companies are similar to NuCryo Vascular Inc.?
Companies similar to NuCryo Vascular Inc. include Bio Molecular Technologies Inc., Keystone Dental Group, and Wellell.
Where is NuCryo Vascular Inc. headquartered?
NuCryo Vascular Inc. is headquartered at 2182;2184;2186;2188;2190;2192 Bering Drive, San Jose.
What is the official website for NuCryo Vascular Inc.?
The official website for NuCryo Vascular Inc. is polarcath.com.
What is the annual revenue of NuCryo Vascular Inc.?
The annual revenue of NuCryo Vascular Inc. is $5M - $20M.
How many employees does NuCryo Vascular Inc. have?
NuCryo Vascular Inc. has 11 - 50 employees.
What industry is NuCryo Vascular Inc. in?
NuCryo Vascular Inc. is in the Medical Device industry.
Last updated: June 19, 2025